Manmill Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 1.00 M
as on 19-12-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 235.94%
(FY 2023)
- Profit 440.46%
(FY 2023)
- Ebitda 609.17%
(FY 2023)
- Net Worth 59.51%
(FY 2023)
- Total Assets 58.67%
(FY 2023)
About Manmill Sciences
The Corporate was formerly known as Saugaum Developers Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Gautam Shah and Sonal Shah serve as directors at the Company.
- CIN/LLPIN
U74110MH2008PTC187588
- Company No.
187588
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2008
- Date of AGM
21 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Manmill Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Shah  | Director | 16-Oct-2008 | Current |
| Sonal Shah | Director | 16-Oct-2008 | Current |
Financial Performance of Manmill Sciences.
Manmill Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 235.94% increase. The company also saw a substantial improvement in profitability, with a 440.46% increase in profit. The company's net worth Soared by an impressive increase of 59.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manmill Sciences?
Unlock access to Manmill Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Novo Excipients Private LimitedActive 21 years 3 monthsGautam Shah and Sonal Shah are mutual person
Metaverse Pharmaceuticals Private LimitedActive 2 years 7 monthsGautam Shah and Sonal Shah are mutual person
- Vitamystic Healthcare Private LimitedActive 2 years 11 months
Gautam Shah and Sonal Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Manmill Sciences?
Unlock and access historical data on people associated with Manmill Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manmill Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manmill Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
